Iranian Firm Produces Nanoliposomal Doxorubicin to Treat Cancer
Ketabi, the marketing manager of Exir Nano Sina company, underlined the therapeutic effects of nanoliposomal doxorubicin in cancer treatment and the role of nanocurcumin in COVID-19 produced by the company.
He also referred to the production of first injectable anti-cancer nanomedicine product in the country with the scientific participation of Mashhad Faculty of Pharmacy, saying that these products are mainly made by lipid-based formulations in two forms of liposomal and nanomicelle.
Ketabi noted that using nanotechnology in these products increases their effectiveness and decreases their toxicity compared to other samples.
In a relevant development earlier this year, Iranian researchers developed a technique using nanoparticles to detect cancer spots using semiconductor quantum dots (QDs).
"Producing quantum dot (QD) superluminescent light emitting diode (SLED) for optical and biological applications" is the title of a project completed by Mehdi Molayee, a professor of Valiasr University in Rafsanjan, in the Southeastern province of Kerman.
Molayee said that the technique has applications such as detecting the location of cancerous tumors in addition to their uses in lasers, sensors and cells.
“In the field of nanomaterials, nanosemiconductors, especially nanosemiconductors of group II-VI, have attracted more attention due to their broad applications,” he said.
He added nanosemiconductors have broad applications in different optical, electronic and biological fields.
Semiconductor quantum dots (QDs) are exciting choice for bioimaging applications, notably in cancer imaging, the Iranian researcher said.
4155/v
